Clinical Trials Directory

Trials / Completed

CompletedNCT00593814

GORE EXCLUDER® Endoprosthesis - Low Permeability in Treatment of Abdominal Aortic Aneurysms

A Clinical Evaluation of the GORE EXCLUDER® Bifurcated Endoprosthesis - Low Permeability in the Primary Treatment of Infrarenal Abdominal Aortic Aneurysms

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
139 (actual)
Sponsor
W.L.Gore & Associates · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the performance of the GORE EXCLUDER® Bifurcated Endoprosthesis-Low Permeability in the primary treatment of infrarenal abdominal aortic aneurysms.

Conditions

Interventions

TypeNameDescription
DEVICEGORE EXCLUDER® Bifurcated Endoprosthesis-Low PermeabilityImplant

Timeline

Start date
2005-06-01
Primary completion
2009-02-01
Completion
2009-02-01
First posted
2008-01-15
Last updated
2018-01-08
Results posted
2010-08-23

Source: ClinicalTrials.gov record NCT00593814. Inclusion in this directory is not an endorsement.

GORE EXCLUDER® Endoprosthesis - Low Permeability in Treatment of Abdominal Aortic Aneurysms (NCT00593814) · Clinical Trials Directory